Back to top
Dr Anna Moltó

Dr Anna Moltó

Attending rheumatologist

Dr Anna Moltó is an attending rheumatologist in the Rheumatology Department of Cochin Hospital, Paris, France, and also acts as a clinical researcher in the INSERM ECAMO team (U-1153) from the University of Paris, France.

 

She completed both her medical studies and rheumatology training at Universitat Autónoma de Barcelona, Spain, in 2010. She completed a clinical research fellowship in Paris, and in 2011, was an assistant professor at Cochin Hospital. Dr Moltó was co-opted by Emerging EULAR Network (EMEUNET) in 2010, where she first served as part of the Country Liaisons subgroup, subsequently as its leader. She was elected Chair of EMEUNET in 2015.

 

Dr Moltó’s research focuses mainly on the natural history of early axial spondyloarthritis, evaluation of effectiveness in observational trials and pregnancy outcomes in patients with inflammatory rheumatic diseases. She has authored more than 100 peer-reviewed publications.

0 resources
You are currently seeing only Dermatology content
Image
Video_15_03.31.png
Video41:11 min
Navigating the new European S2k guidelines for hidradenitis suppurativa: How will they change your clinical practice?

Unlock the European S2k HS guidelines. Prof. Tzellos and Prof. Bechara share expert insights and implications of the updated guidelines

EU-BK-2500021
Image
Video_14_02.02.png
Video6:55 min
Setting up MDT care in HS: Learning from psoriasis

Establishing a multidisciplinary team to alleviate disease burden and optimise patient outcomes, using the principles of value-based healthcare

EU-DA-2400507
Image
250715_Use of imaging in HS management_thumbnail Med Hub.png
Video6:30 min
Use of imaging in HS management

Transformative role of ultrasound and magnetic resonance imaging in HS management, and how AI-driven technologies may enhance disease characterisation

EU-DA-2400506
Image
Video_12_1.51.png
Video4:25 min
Evidence-based approach to medical management based on the European guidelines for HS

Latest evidence-based strategies for effective HS medical management including antibiotics and biologic therapy

EU-BK-2400332